Ian Bezek

Ian Bezek

InvestorPlace Contributor

Ian Bezek earned his economics degree from Colorado State University in 2010. He then worked as an analyst for Kerrisdale Capital, a New York City-based activist hedge fund, from 2011-13. Since then, Ian has focused on finding under-the-radar investment opportunities, particularly overseas. To that end, he taught himself Spanish and has lived in Mexico and Argentina among other countries. He currently resides in Colombia with his family.

You can interact with Ian on Twitter.

Recent Articles

Nope, It’s Not Yet Time to Buy Canopy Growth

By Ian Bezek, InvestorPlace Contributor

Canopy Growth stock has rallied sharply in recent days. But these key factors will snuff out the rally in CGC stock in coming weeks.

The Loxo Oncology Purchase Eventually Could Help Eli Lilly Stock

By Ian Bezek, InvestorPlace Contributor

Eli Lilly offers a massive premium, paying $8 billion to buy Loxo Oncology. What's in it for Lilly and its shareholders?

Things Are Going to Keep Getting Worse for Square Stock

By Ian Bezek, InvestorPlace Contributor

Square's core business is still struggling to make consistent profits. Tech stock selling and mounting credit risk complicate matters further.

Bank of America Stock Should Rebound 20% in the Coming Months

By Ian Bezek, InvestorPlace Contributor

Bank of America looks set for a rebound to $30/share. Here are the reasons why that should happen in 2019.

Should Activision Stock Be Bought on Weakness?

By Ian Bezek, InvestorPlace Contributor

Activision stock is still facing multiple, significant risks, even after ATVI dropped sharply in recent months.

Micron Stock Is Getting Cheaper, but Don’t Buy Until This Happens

By Ian Bezek, InvestorPlace Contributor

Micron stock has lost half its value since this past summer. Surely it can't get much worse? Yet despite looking cheap at this price, MU stock still has some issues to work through.

Facebook Stock Finally Has Found the Bottom and Will Build a Great 2019

By Ian Bezek, InvestorPlace Contributor

Citron Research recently gave Facebook the thumb's up and suggested the stock is worth $160 per share. Here's why they're probably going to end up being correct on that call.

Despite the Market Storm, CRM Stock Is a Bargain at These Prices

By Ian Bezek, InvestorPlace Contributor

Salesforce stock is getting hammered this week. That's dropped it into the buy zone according to this important metric.

Elon Musk’s Boring Announcement Should Scare Tesla Bulls

By Ian Bezek, InvestorPlace Contributor

Tesla stock is slumping again due to Elon Musk's latest antics. But there's one reason why TSLA may be a buy anyway.

7 Trade War Losers Set to Become Big 2019 Winners

By Ian Bezek, InvestorPlace Contributor

These will be great stocks to buy for your portfolio once the U.S. and China reach a new trade deal and the trade war is behind us.

Load More